Relevant bibliographies by topics / Mastectomy / Journal articles
To see the other types of publications on this topic, follow the link: Mastectomy.

Journal articles on the topic 'Mastectomy'

Author: Grafiati
Published: 4 June 2021
Last updated: 30 July 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Mastectomy.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Lima, Maria Monica Galdino de, Kamila Nethielly Souza Leite, Mona Lisa Lopes dos Santos, Erta Soraya Ribeiro César, Talita Araújo de Souza, Bruno Bezerra do Nascimento, Joseli Pereira Barboza, and Tamires Marques Dantas. "Sentimentos vivenciados pelas mulheres mastectomizadas." Revista de Enfermagem UFPE on line 12, no. 5 (May 1, 2018): 1216. http://dx.doi.org/10.5205/1981-8963-v12i5a231094p1216-1224-2018.

Full text
Abstract:
RESUMOObjetivo: desvelar os sentimentos das mulheres mastectomizadas. Método: estudo quantiqualitativo, descritivo e exploratório. O universo populacional foi de 35 mulheres que fazem parte da associação “Amigas viva a vida” e amostra foi constituída por 25. O instrumento de coleta de dados foi um questionário semiestruturado, os dados estatísticos foram analisados de acordo com suas variáveis e os dados qualitativos foram analisados pelo DSC. Os resultados foram expressos em tabelas e figuras. Resultados: em relação aos aspectos clínicos, a maioria realizou mastectomia total e a metade a reconstrução mamária. A perda da mama acarretou em prejuízos físicos, porém, a forma como cada uma passou pelo processo de adoecimento e tratamento estava associada aos significados que atribuíram a doença. Conclusão: após o tratamento, os sentimentos vivenciados pelas mulheres foram parecidos, mas que a tristeza, a dor estiveram sempre presentes. Assim, os resultados desse estudo proporcionam um novo olhar na comunidade científica promovendo novas possibilidades de abordagens temáticas com as mulheres mastectomizadas. Descritores: Saúde da Mulher; Mastectomia; Emoções; Neoplasias da Mama; Autoimagem; Trauma Psicológico.ABSTRACTObjective: to reveal the feelings of women with mastectomy. Method: this is a quantitative, qualitative, descriptive and exploratory study. The population universe consisted of 35 women who are part of the "Amigas viva a vida" association and sample consisted of 25. The data collection instrument was a semi-structured questionnaire, statistical data were analyzed according to their variables and qualitative data were analyzed by the DSC. The results were expressed in tables and figures. Results: Regarding the clinical aspects, most participants performed a total mastectomy, and half had the mammary reconstruction. The loss of the breast resulted in physical damage, but the way each one went through the process of illness and treatment was associated with the meanings that attributed the disease. Conclusion: After the treatment, the feelings experienced by the women were similar, but that sadness and the pain were always present. Thus, the results of this study provide a new perspective on the scientific community promoting new possibilities for thematic approaches with women with mastectomy. Descriptors: Women's Health; Mastectomy; Emotions; Breast neoplasms; Self-image; Psychological Trauma.RESUMENObjetivo: desvelar los sentimientos de las mujeres con mastectomía. Método: estudio cuantitativo y cualitativo, descriptivo y exploratorio. El universo populacional fue de 35 mujeres que forman parte de la asociación “Amigas viva a vida” y la muestra fue constituida por 25. El instrumento de recolección de datos fue un cuestionario semi-estructurado, los datos estadísticos fueron analizados de acuerdo con sus variables y los datos cualitativos fueron analizados por el DSC. Los resultados fueron expresados en tablas y figuras. Resultados: en relación a los aspectos clínicos, la mayoría realizó mastectomía total, y la mitad la reconstrucción mamaria. La pérdida de la mama tuvo perjucios físicos, pero, la forma como cada una pasó por el proceso de enfermarse y tratamiento está asociado a los significados que atribuyeron a la enfermedad. Conclusión: después del tratamiento, los sentimientos vividos por las mujeres fueron parecidos, pero que la tristeza, y el dolor estuvieron siempre presentes. Así, los resultados de ese estudio proporcionan un nuevo punto de vista en la comunidad científica promoviendo nuevas posibilidades de enfoques temáticas con las mujeres con mastectomía. Descriptores: Salud de la Mujer; Mastectomía; Emociones; Neoplasias de la Mama; Autoimagen; Trauma Psicológica.
APA, Harvard, Vancouver, ISO, and other styles
2

Lima, Camila Gomes de, Giovana Mendes de Lacerda, Izabel Cristina Santiago Lemos de Beltrão, Dailon de Araújo Alves, and Grayce Alencar Albuquerque. "Impacto do Diagnóstico e do Tratamento do Câncer de Mama em Mulheres Mastectomizadas." Ensaios e Ciência C Biológicas Agrárias e da Saúde 24, no. 4 (December 2, 2020): 426–30. http://dx.doi.org/10.17921/1415-6938.2020v24n4p426-430.

Full text
Abstract:
O câncer de mama (CM) é uma neoplasia que acomete principalmente pessoas do sexo feminino. O tratamento para o CM engloba intervenções locais, tais como: as cirurgias conservadoras e a mastectomia e/ou intervenções sistêmicas. Desse modo, o objetivo do presente estudo foi compreender o impacto do diagnóstico e do tratamento do CM para mulheres que foram submetidas à mastectomia. O estudo é descritivo-exploratório com abordagem qualitativa, realizado na cidade de Barbalha, Ceará. Para organização, análise e interpretação dos dados foi utilizada a categorização temática de Minayo. Participaram da pesquisa 11 mulheres na faixa etária de 25 a 55 anos. Utilizando a análise proposta, foram elencadas três categorias: “câncer de mama e seu significado”; “diagnóstico do câncer: mudanças e tratamento” e “mastectomia e feminilidade”. Observou-se que as mulheres submetidas à mastectomia precisam expressar resiliência para prosseguir com o tratamento e para lidar, de forma positiva, com as alterações percebidas na imagem corporal. Assim, a análise dos dados permitiu concluir que o diagnóstico e os impactos com o tratamento contemplam aspectos biológico, psíquico e social. Portanto, pelo fato dessas mulheres sofrerem diversas alterações em suas rotinas diárias, elas necessitam de sistemas de apoio congruentes e alicerçados no âmbito assistencial, familiar e comunitário. Palavras-chave: Neoplasia. Mastectomia. Saúde da Mulher. Abstract Breast cancer (BC) affects especially women. Treatment for BC involves local interventions - such as conservative surgery and mastectomy - and/or systemic therapy. Thus, the aim of the present study was to understand the impact of BC diagnosis and treatment for women undergoing mastectomy. The study is descriptive and exploratory with qualitative approach, conducted in the city of Barbalha, Ceará. For data organization, analysis and interpretation, Minayo's thematic categorization was used. Eleven women aged 25 to 55 years participated in the research. Using the proposed analysis, three categories were listed: “breast cancer and its meaning”; “Cancer diagnosis: changes and treatment” and “mastectomy and femininity”. It has been observed that women undergoing mastectomy need to express resilience to proceed with treatment and to deal positively with perceived changes in body image. Thus, the data analysis allowed to conclude that the diagnosis and the impacts with the treatment include biological, psychic and social aspects. Therefore, because these women suffer several changes in their daily routines, they need congruent support systems based on care, family and community. Keywords: Neoplasia. Mastectomy. Women's Health.
APA, Harvard, Vancouver, ISO, and other styles
3

Pender, Kelly, Daleela Dodge, and Jessica M. Collins. "Preserving choice in breast cancer treatment: A different perspective on contralateral prophylactic mastectomy." Women's Health 19 (January 2023): 174550572311758. http://dx.doi.org/10.1177/17455057231175812.

Full text
Abstract:
Contralateral prophylactic mastectomy is the removal of both breasts when only one is affected by cancer. Rates of this controversial cancer treatment have been increasing since the late 1990s, even among women who do not have the kind of family history or known genetic mutation that would put them at high-risk for another breast cancer. Citing contralateral prophylactic mastectomy’s lack of oncologic benefit and increased risk of surgical complications, the American Society of Breast Surgeons discourages contralateral prophylactic mastectomy for average-risk women with unilateral cancer, as does most of the medical literature on this topic. Within this literature, desire for contralateral prophylactic mastectomy is often painted as the product of an emotional overreaction to a cancer diagnosis and misunderstanding of breast cancer risk. Drawing on the personal experience of a breast cancer survivor, as well as relevant medical literature on breast cancer screening and surgery, this article offers a different perspective on the ongoing popularity of contralateral prophylactic mastectomy, one that focuses on practical experiences and logical deliberations about those experiences. Specifically, it calls attention to two features of the contralateral prophylactic mastectomy decision-making situation that have been inadequately covered in the medical literature: (1) the way that breast cancer screening after a breast cancer diagnosis can become a kind of radiological overtreatment, even for “average-risk” women; and (2) how desire for bodily symmetry after breast cancer, which can best be achieved through bilateral reconstruction or no reconstruction, drives interest in contralateral prophylactic mastectomy. The goal of this article is not to suggest that all women who want contralateral prophylactic mastectomy should have the surgery. In some cases, it is not advisable. But many “average-risk” women with unilateral cancer have good reasons for wanting contralateral prophylactic mastectomy, and we believe their right to choose it should be protected.
APA, Harvard, Vancouver, ISO, and other styles
4

Bafile, A., and M. Mascio. "Subcoutaneous mastectomy versus submuscular mastectomy." Breast 44 (March 2019): S111. http://dx.doi.org/10.1016/s0960-9776(19)30377-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Varela, Ana Inêz Severo, Luciana Martins da Rosa, Natália Sebold, Ana Gabriela Laverde, Amarildo Maçaneiro, and Alacoque Lorenzini Erdmann. "COMPROMETIMENTO DA SEXUALIDADE DE MULHERES COM CÂNCER DE MAMA." Enfermagem em Foco 8, no. 1 (April 7, 2017): 67. http://dx.doi.org/10.21675/2357-707x.2017.v8.n1.764.

Full text
Abstract:
Objetivo: identificar os obstáculos relacionados à sexualidade e à vida sexual de mulheres com câncer de mama. Metodologia: pesquisa descritiva, que incluiu dez mulheres submetidas à mastectomia ou quandrantectomia residentes no município de Florianópolis, selecionadas pelo método bola de neve. Dados obtidos por entrevistas semiestruturadas, realizadas entre março e maio de 2014, submetidos à análise de conteúdo e sustentados teoricamente por estudos afins. Resultados: os obstáculos encontrados envolvem o enfrentamento familiar e pessoal comprometidos e a alteração sexual e ginecológica. Conclusão: apesar do avanço científico e tecnológico, permanece a necessidade de cuidado integral e individualizado à mulher, aos companheiros e aos familiares.Descritores: Sexualidade, Neoplasias da mama, Mastectomia, Enfermagem.COMMITMENT TO SEXUALITY OF WOMEN WITH BREAST CANCERObjective: Identify obstacles related to sexuality and sexual life of women with breast cancer. Methodology: descriptive study, which included ten women undergoing mastectomy or quandrantectomia, residents in Florianopolis, selected by snowball method. Data from semistructured interviews, conducted between March and May 2014 and submitted to content analysis and theoretically supported by related studies. Results: The obstacles encountered includes confrontation of family and personal commitment and sexual and gynecological change. Conclusion: Despite the scientific and technological advances remain the need for comprehensive care and individualized to women, to companion and family.Descriptors: Sexuality, Breast neoplasms, Mastectomy, Nursing.COMPROMISO DE LA SEXUALIDAD DE LAS MUJERES CON CÁNCER DE MAMAObjetivo: Identificar los obstáculos relacionados con la sexualidad y la vida sexual de las mujeres con cáncer de mama. Metodología: estudio descriptivo, que incluía diez mujeres sometidas a mastectomía o quandrantectomia, residentes en Florianópolis, seleccionados por el método bola de nieve. Los datos recogidos por entrevistas semi-estructuradas, entre marzo y mayo de 2014, sometido a análisis de contenido y, en teoría apoyada por estudios relacionados. Resultados: Los obstáculos encontrados implican hacer frente familia y la evolución sexual y ginecológica personal y comprometido. Conclusión: A pesar de los avances científicos y tecnológicos continúa la necesidad de una atención integral e individualizada a las mujeres, compañeros y familiares.Descriptores: Sexualidad, Neoplasias de la mama, Mastectomía, Enfermería.
APA, Harvard, Vancouver, ISO, and other styles
6

Gunn, S. W. A. "Mastectomy." World Journal of Surgery 22, no. 5 (May 1998): 425–26. http://dx.doi.org/10.1007/bf03356098.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Singer, Sarah. "Mastectomy." JAMA: The Journal of the American Medical Association 270, no. 14 (October 13, 1993): 1754. http://dx.doi.org/10.1001/jama.1993.03510140116048.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Souza, Michelle Freitas de, and Fatima Helena do Espírito Santo. "Tecnologias educativas como orientação em pós operatório de mastectomia." Revista Recien - Revista Científica de Enfermagem 12, no. 40 (December 19, 2022): 185–93. http://dx.doi.org/10.24276/rrecien2022.12.40.185-193.

Full text
Abstract:
Caracterizar a produção cientifica acerca das tecnologias educativas nos cuidados de pós operatório de mastectomia. Revisão integrativa de literatura que tem como modo de pesquisa que concede a busca, análise crítica e a síntese das evidências acessíveis acerca de um assunto a ser investigado em que, o desfecho é a compreensão da temática investigada. Evidenciou-se que o uso das tecnologias educativas na saúde seja por cartilhas, manuais, formulários e vídeo são formas de transmissão do conhecimento e informações que visam, orientar, interagir e divulgar conteúdos que contribuam na disseminação do conhecimento. As tecnologias educativas estão cada vez mais sendo utilizadas por profissionais de saúde, principalmente, pelos enfermeiros, porque através do ensino e aprendizagem é possível transmitir e difundir o conhecimento, facilitando a comunicação, compreensão das orientações de cuidado e autocuidado com intuito estimular a autogestão do cuidado do paciente. Descritores: Tecnologia Educacional, Cuidados Pós-Operatórios, Mastectomia. Educational technologies as guidance in post-mastectomy surgery Abstract: To characterize the scientific production on educational technologies in post-mastectomy care. An integrative literature review that has as a research mode that grants the search, critical analysis and synthesis of accessible evidence about a subject to be investigated in which, the outcome is the understanding of the investigated theme. It was evidenced that the use of educational technologies in health, whether through booklets, manuals, forms and video, are ways of transmitting knowledge and information that aim to guide, interact and disseminate content that contributes to the dissemination of knowledge. Educational technologies are increasingly being used by health professionals, especially nurses, because through teaching and learning it is possible to transmit and disseminate knowledge, facilitating communication, understanding of care and self-care guidelines in order to stimulate self-management of the patient care. Descriptors: Educational Technology, Postoperative Care, Mastectomy. Tecnologías educativas como guía en la cirugía pos mastectomía Resumen: Caracterizar la producción científica sobre tecnologías educativas en la atención posmastectomía. Revisión integradora de literatura que tiene como modo de investigación que otorga la búsqueda, análisis crítico y síntesis de evidencia accesible sobre un tema a investigar en el que el resultado es la comprensión del tema investigado. Se evidenció que el uso de tecnologías educativas en salud, ya sea a través de cartillas, manuales, formularios y videos, son formas de transmisión de conocimientos e informaciones que tienen como objetivo orientar, interactuar y difundir contenidos que contribuyan a la difusión del conocimiento. Las tecnologías educativas están siendo cada vez más utilizadas por los profesionales de la salud, principalmente por los enfermeros, pues a través de la enseñanza y el aprendizaje es posible transmitir y difundir conocimientos, facilitando la comunicación, la comprensión de los cuidados y las pautas de autocuidado con el fin de estimular la autogestión del cuidado del paciente. Descriptores: Tecnología Educacional, Cuidados Posoperatorios, Mastectomía.
APA, Harvard, Vancouver, ISO, and other styles
9

Boyd, Carter J., Gaines Blasdel, William J. Rifkin, Amber A. Guth, Deborah M. Axelrod, and Rachel Bluebond-Langner. "Gender-affirming Mastectomy with Concurrent Oncologic Mastectomy." Plastic and Reconstructive Surgery - Global Open 10, no. 2 (February 2022): e4092. http://dx.doi.org/10.1097/gox.0000000000004092.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Chagpar, Anees B. "Prophylactic Bilateral Mastectomy and Contralateral Prophylactic Mastectomy." Surgical Oncology Clinics of North America 23, no. 3 (July 2014): 423–30. http://dx.doi.org/10.1016/j.soc.2014.03.008.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Basilio, Franciane Batista, Raphaela Medeiros Miranda Anjos, Elany Pereira Medeiros, Elaine Marques Franco Melo, and Rodrigo Marcel Valentim Silva. "Effects of manual therapy techniques in the treatment of pain in post mastectomy patients: systematic review." Manual Therapy, Posturology & Rehabilitation Journal 12 (September 2, 2014): 190. http://dx.doi.org/10.17784/mtprehabjournal.2014.12.190.

Full text
Abstract:
Introduction: Cancer is now the third leading cause of death in the world, surpassed only by accidents and cardiovascular deaths by external causes, among them stands mammary carcinoma. Mastectomy is in a procedure consisting of invasive breast removal due to some anatomical and functional changes previously diagnosed. With the growth of the disease and its high content in increasingly young women, Manual Therapy has been used as a new form of treatment. Objective: To show the effects of manual therapy in patients after mastectomy surgery. Method: This was a systematic review study in which secondary and tertiary sources were used, using the databases PubMed, Medline, Lilacs and SciELO. It was adopted as inclusion criteria studies classified as: a randomized controlled trial, with publication period between 2009 and 2013. Were used as search terms: "Mastectomy", "Neck", "Shoulder Pain", "Musculoskeletal Manipulations" and "Functionality". Results: Among the 37 initially selected by electronic search in the databases of articles, 25 were excluded for the title did not meet the inclusion criteria. Of the 12 retained studies, 5 were excluded for duplicity. 7 studies were selected for a more thorough analysis through summary, 2 of them being excluded. The remaining 5 articles were evaluated from reading the text. It can be seen that the manual therapy techniques have significant results in the alleviation of muscle pain in patients submitted to surgery mastectomia. Conclusion: It can be seen that the manual therapy techniques have significant results in the alleviation of muscle pain in patients undergoing the mastectomy surgery. However, there is still a lack of studies of type randomized controlled trial on the effects of manual therapy in patients in the postoperative period of mastectomy
APA, Harvard, Vancouver, ISO, and other styles
12

Khurana, Kamal K., Anne Loosmann, Patricia J. Numann, and Seema A. Khan. "Prophylactic Mastectomy." Archives of Pathology & Laboratory Medicine 124, no. 3 (March 1, 2000): 378–81. http://dx.doi.org/10.5858/2000-124-0378-pmpfih.

Full text
Abstract:
Abstract Background.—According to recently published data, prophylactic mastectomy (PM) appears to prevent about 90% of the expected malignant neoplasms in women with a family history of breast cancer. Objectives.—To identify the frequency of high-risk lesions in PM specimens and to determine occurrence of any new primary breast cancer following PM. Design.—We performed a retrospective study of women undergoing unilateral or bilateral PM. Medical charts and pathologic findings of 35 patients who underwent bilateral mastectomies at University Hospital, Syracuse, NY, from 1989 to 1996 were reviewed. Patients with biopsy-proven bilateral breast cancer were excluded. Patients were divided into 3 groups: (A) positive family history and no known breast cancer (n = 9), (B) positive family history and contralateral neoplasia (n = 13), and (C) negative family history and contralateral neoplasia (n = 13). These findings were compared with those found in reduction mammoplasty specimens from 10 women at standard risk of breast cancer. Results.—The mean age of the control group of women undergoing reduction mammoplasty was 38 years. The pathologic specimens demonstrated no significant pathologic findings in 9 and fibrocystic change in 1. In group A, the mean number of affected relatives was 3.1, and the mean age was 38 years. Two of these 9 women had atypical duct hyperplasia and 1 had atypical lobular hyperplasia in their breasts (ie, 33% with high-risk pathologic findings). Of the 13 group B women (mean age, 46.6 years; mean of 2.5 affected relatives and unilateral breast cancer), the contralateral PM specimen contained duct carcinoma in situ in one and invasive ductal cancer in a second (15% with occult malignant neoplasms). In 13 group C patients (mean age, 47.1 years), 3 (23.1%) of the contralateral PM specimens displayed atypical duct hyperplasia or atypical lobular hyperplasia. At a mean follow-up of 4.8 years, there have been no new breast malignant neoplasms in these 45 women. Conclusions.—The occurrence of unilateral cancer in patients with family history of breast cancer is associated with a 15.4% probability of simultaneous occult malignant neoplasms in the contralateral breast. Patients with a strong family history but no evidence of breast cancer have a substantially similar rate of proliferative disease in their PM specimens as those women who have unilateral cancer but no significant family history.
APA, Harvard, Vancouver, ISO, and other styles
13

Bruce, Madeleine K., Walter J. Joseph, Lorelei Grunwaldt, Vu T. Nguyen, and Carolyn De La Cruz. "Transgender Mastectomy." Annals of Plastic Surgery 88, no. 3 (May 2022): S148—S151. http://dx.doi.org/10.1097/sap.0000000000003175.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Goodwin, Peter M. "Double Mastectomy." Oncology Times 40, no. 9 (May 2018): 36. http://dx.doi.org/10.1097/01.cot.0000533702.45184.15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Simmons, Rache M., and Michael P. Osborne. "Prophylactic Mastectomy." Breast Journal 3, no. 6 (November 1997): 372–79. http://dx.doi.org/10.1111/j.1524-4741.1997.tb00196.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Frechette, C. N. "SUBCUTANEOUS MASTECTOMY." Plastic and Reconstructive Surgery 86, no. 1 (July 1990): 166. http://dx.doi.org/10.1097/00006534-199007000-00048.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Jarrett, John. "Subcutaneous Mastectomy." Seminars in Plastic Surgery 4, no. 01 (1990): 81–93. http://dx.doi.org/10.1055/s-2008-1080437.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Snyderman, R. K. "Prophylactic mastectomy." Plastic and Reconstructive Surgery 75, no. 1 (January 1985): 142. http://dx.doi.org/10.1097/00006534-198501000-00062.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

van Geel, A. N. "Prophylactic mastectomy." Breast 12 (March 2003): S3. http://dx.doi.org/10.1016/s0960-9776(03)80002-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Newman, Lisa A., Henry M. Kuerer, Kelly K. Hunt, Georges Vlastos, Frederick C. Ames, Merrick I. Ross, and S. Eva Singletary. "Prophylactic mastectomy." Journal of the American College of Surgeons 191, no. 3 (September 2000): 322–30. http://dx.doi.org/10.1016/s1072-7515(00)00361-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Dooley, William C. "Ambulatory mastectomy." American Journal of Surgery 184, no. 6 (December 2002): 545–48. http://dx.doi.org/10.1016/s0002-9610(02)01051-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Pressman, Peter I. "Prophylactic Mastectomy." Surgical Oncology Clinics of North America 2, no. 1 (January 1993): 145–54. http://dx.doi.org/10.1016/s1055-3207(18)30602-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Zakaria, Shaheen, and Amy C. Degnim. "Prophylactic Mastectomy." Surgical Clinics of North America 87, no. 2 (April 2007): 317–31. http://dx.doi.org/10.1016/j.suc.2007.01.009.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Schwartz, Jean-Claude. "Goldilocks Mastectomy." Plastic and Reconstructive Surgery - Global Open 5, no. 6 (June 2017): e1398. http://dx.doi.org/10.1097/gox.0000000000001398.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Gulhrie, Randolph H. "PARTIAL MASTECTOMY." Plastic and Reconstructive Surgery 91, no. 7 (June 1993): 1369. http://dx.doi.org/10.1097/00006534-199306000-00043.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Voelker, R. "Scarless Mastectomy." JAMA: The Journal of the American Medical Association 280, no. 16 (October 28, 1998): 1393—d—1393. http://dx.doi.org/10.1001/jama.280.16.1393-d.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Voelker, Rebecca. "Scarless Mastectomy." JAMA 280, no. 16 (October 28, 1998): 1393. http://dx.doi.org/10.1001/jama.280.16.1393-jqu80007-5-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Bostwick, John. "Preventive mastectomy." Annals of Surgical Oncology 1, no. 6 (November 1994): 455–56. http://dx.doi.org/10.1007/bf02303608.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Osborne, Michael P. "Salvage mastectomy." Seminars in Surgical Oncology 7, no. 5 (September 1991): 291–95. http://dx.doi.org/10.1002/ssu.2980070511.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Olsen, Margaret A., Katelin B. Nickel, Ida K. Fox, Julie A. Margenthaler, Kelly E. Ball, Daniel Mines, Anna E. Wallace, and Victoria J. Fraser. "Incidence of Surgical Site Infection Following Mastectomy With and Without Immediate Reconstruction Using Private Insurer Claims Data." Infection Control & Hospital Epidemiology 36, no. 8 (June 3, 2015): 907–14. http://dx.doi.org/10.1017/ice.2015.108.

Full text
Abstract:
OBJECTIVEThe National Healthcare Safety Network classifies breast operations as clean procedures with an expected 1%–2% surgical site infection (SSI) incidence. We assessed differences in SSI incidence following mastectomy with and without immediate reconstruction in a large, geographically diverse population.DESIGNRetrospective cohort studyPATIENTSCommercially insured women aged 18–64 years with ICD-9-CM procedure or CPT-4 codes for mastectomy from January 1, 2004 through December 31, 2011METHODSIncident SSIs within 180 days after surgery were identified by ICD-9-CM diagnosis codes. The incidences of SSI after mastectomy with and without immediate reconstruction were compared using the χ2 test.RESULTSFrom 2004 to 2011, 18,696 mastectomy procedures among 18,085 women were identified, with immediate reconstruction in 10,836 procedures (58%). The incidence of SSI within 180 days following mastectomy with or without reconstruction was 8.1% (1,520 of 18,696). In total, 49% of SSIs were identified within 30 days post-mastectomy, 24.5% were identified 31–60 days post-mastectomy, 10.5% were identified 61–90 days post-mastectomy, and 15.7% were identified 91–180 days post-mastectomy. The incidences of SSI were 5.0% (395 of 7,860) after mastectomy only, 10.3% (848 of 8,217) after mastectomy plus implant, 10.7% (207 of 1,942) after mastectomy plus flap, and 10.3% (70 of 677) after mastectomy plus flap and implant (P<.001). The SSI risk was higher after bilateral compared with unilateral mastectomy with immediate reconstruction (11.4% vs 9.4%, P=.001) than without (6.1% vs 4.7%, P=.021) immediate reconstruction.CONCLUSIONSSSI incidence was twice that after mastectomy with immediate reconstruction than after mastectomy alone. Only 49% of SSIs were coded within 30 days after operation. Our results suggest that stratification by procedure type facilitates comparison of SSI rates after breast operations between facilities.Infect Control Hosp Epidemiol 2015;36(8):907–914
APA, Harvard, Vancouver, ISO, and other styles
31

Susilawati, Oting, and Agus Santosa. "Innovative post mastectomy bra for increasing self-convenience and confidence patients." MEDISAINS 17, no. 1 (July 25, 2019): 20. http://dx.doi.org/10.30595/medisains.v17i1.4348.

Full text
Abstract:
Background: The act of mastectomy can affect body image because it loses part of the body and affects their social relationships with others. The existed bra is felt uncomfortable when worn so it is necessary to develop a special post mastectomy bra to increase the confidence and comfort of post mastectomy patients.Purpose: This study aimed to examine and develop a special post mastectomy bra to increase self-confidence in post-mastectomy patients.Research Methods: This is a Research and Development (R & D) research. This study consisted of 3 phase, namely research phase I, phase II, and phase III or product testing.Results: The results of a post mastectomy special bra tested to 10 respondents mentioned that a special post mastectomy bra is comfortable to wear and they are not ashamed anymore do activities outside the home.Conclusion: Special post mastectomy bras are proven to increase post-mastectomy patients' convenience and confidence.
APA, Harvard, Vancouver, ISO, and other styles
32

Yao, Katharine. "Abstract ED6-1: Contralateral mastectomy in patients with germline mutations." Cancer Research 83, no. 5_Supplement (March 1, 2023): ED6–1—ED6–1. http://dx.doi.org/10.1158/1538-7445.sabcs22-ed6-1.

Full text
Abstract:
Abstract The educational session titled "Contralateral mastectomy in patients with germline mutations" will cover contralateral mastectomy in affected gene carriers. The session will first cover trends in contralateral mastectomy in germline mutation carriers and the impact of genetic testing on contralateral mastectomy utilization. Second, the session will review guidelines on contralateral mastectomy for gene carriers. Literature on potential beneficial impacts of contralateral mastectomy for gene carriers will be reviewed. Impact to contralateral risk, survival outcomes and patient quality of life will be examined. Lastly, the session will review new surgical approaches for prophylactic mastectomy and protocols to reduce pain and enhance recovery after mastectomy. Citation Format: Katharine Yao. Contralateral mastectomy in patients with germline mutations [abstract]. In: Proceedings of the 2022 San Antonio Breast Cancer Symposium; 2022 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2023;83(5 Suppl):Abstract nr ED6-1.
APA, Harvard, Vancouver, ISO, and other styles
33

Kim, Jiwoo, Hajime Matsumine, Yosuke Niimi, Atsuyoshi Osada, and Hiroyuki Sakurai. "Estimation of Mastectomy Volume Using Preoperative Mastectomy Simulation Images Acquired by the Vectra H2 System." Plastic and Reconstructive Surgery - Global Open 11, no. 8 (August 2023): e5180. http://dx.doi.org/10.1097/gox.0000000000005180.

Full text
Abstract:
Background: Preoperative prediction of breast volume is very important in planning breast reconstruction. In this study, we assessed the usefulness of a novel method for preoperative estimation of mastectomy volume by comparing the weight of actual mastectomy specimens with the values predicted by the developed method using the Vectra H2. Methods: All patients underwent skin-sparing mastectomy and immediate autologous breast reconstruction. Preoperatively, the patient’s breast was scanned using the Vectra H2 and a postmastectomy simulation image was constructed on a personal computer. The estimated mastectomy volume was calculated by comparing the preoperative and postmastectomy three-dimensional simulation images. Correlation coefficients with the estimated mastectomy volume were calculated for the actual mastectomy weight and the transplanted flap weight. Results: Forty-five breasts of 42 patients were prospectively analyzed. The correlations with the estimated mastectomy volume were r = 0.95 (P < 0.0001) for actual mastectomy weight and r = 0.84 (P < 0.0001) for transplanted free-flap weight. The mastectomy weight estimation formula obtained by linear regression analysis using the estimated mastectomy volume was 0.98 × estimated mastectomy volume + 5.4 (coefficient of determination R2 = 0.90, P < 0.0001). The root-mean-square error for the mastectomy weight estimation formula was 38 g. Conclusions: We used the Vectra H2 system to predict mastectomy volume. The predictions provided by this method were highly accurate. Three-dimensional imaging is a noncontact, noninvasive measurement method that is both accurate and simple to perform. Use of this effective tool for volume prediction is expected to increase in the future.
APA, Harvard, Vancouver, ISO, and other styles
34

Rosenberg, Karen. "Mastectomy Rates Rising in Women who Donʼt Require Mastectomy." AJN, American Journal of Nursing 115, no. 2 (February 2015): 56. http://dx.doi.org/10.1097/01.naj.0000460695.32758.92.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Damle, Sameer, Christine B. Teal, Joanne J. Lenert, Elizabeth C. Marshall, Qing Pan, and Anita P. McSwain. "Mastectomy and Contralateral Prophylactic Mastectomy Rates: An Institutional Review." Annals of Surgical Oncology 18, no. 5 (December 2, 2010): 1356–63. http://dx.doi.org/10.1245/s10434-010-1434-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Damle, Sameer, Christine B. Teal, Joanne J. Lenert, Elizabeth C. Marshall, Qing Pan, and Anita P. McSwain. "Mastectomy and Contralateral Prophylactic Mastectomy Rates: An Institutional Review." Indian Journal of Surgical Oncology 2, no. 2 (June 2011): 133–40. http://dx.doi.org/10.1007/s13193-011-0086-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Frey, Jordan D., Ara A. Salibian, Mihye Choi, and Nolan S. Karp. "Mastectomy Flap Thickness and Complications in Nipple-Sparing Mastectomy." Plastic and Reconstructive Surgery - Global Open 5, no. 8 (August 2017): e1439. http://dx.doi.org/10.1097/gox.0000000000001439.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Falco, Giuseppe, Annalisa Curcio, Francesco Marongiu, Federico Buggi, Matteo Mingozzi, Simone Mele, Guglielmo Ferrari, and Secondo Folli. "Bipedicled Nipple-Sparing Mastectomy Versus Traditional Nipple-Sparing Mastectomy." Annals of Plastic Surgery 84, no. 4 (April 2020): 366–74. http://dx.doi.org/10.1097/sap.0000000000002166.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Indriyanto, Slamet. "BODY IMAGE DIFFERENCES IN BODY IMAGE BETWEEN BEFORE AND AFTER MASTECTOMY TO BREAST CANCER CLIENTS AT RSUD DR. SAIFUL ANWAR MALANG." Jurnal Ilmiah Kesehatan Media Husada 11, no. 2 (November 10, 2022): 165–73. http://dx.doi.org/10.33475/jikmh.v11i2.279.

Full text
Abstract:
ABSTRACT Indriyanto, Slamet. 2021. Differences in Body Image Between Before And After Mastectomy To Breast Cancer Clients At RSUD Dr. Saiful Anwar Malang. Thesis. Bachelor of Nursing, Maharani Health College Malang. Supervisors: (1) Ns. Wiwik Agustina, S.Kep., M. Biomed, (2) Ns. Rahmawati Maulidia, M.Kep. Breast cancer is one of the most common types of cancer in Indonesia and mastectomy is a rational and effective treatment procedure to prevent the spread and disposal of cancer cells. Body image undergoes many changes during breast cancer therapy and treatment, the impact of these changes affects client perception, sexuality, and social function. The purpose of this study is to identify body image before and after the mastectomy, and whether there is a change in body image between before and after the mastectomy. The study used the BREAST-Q Version 2.0 Mastectomy Module and Pre-Post Operative Scales questionnaire. The design of this study is comparative study with cross sectional analysis. The results of the study, obtained body image before mastectomy almost all respondents (90%) with negative body image. While body image after mastectomy, obtained by all respondents (100%) have a negative body image. Wilcoxon signed rank test results showed a difference in body image between before and after the mastectomy, with a value of p: 0.005 smaller than α= 0.05 Body image has changed before the mastectomy, even decreasing after the mastectomy. Keywords: Breast Cancer, Body image, Mastectomy.
APA, Harvard, Vancouver, ISO, and other styles
40

Ahmed, Dr Istiak, Professor Dr Md Baharul Islam, Dr Rupsha Nura Laila, and Dr Md Munzur Rahman. "Outcome and Evaluation of Mastectomy with Axillary Dissection in Stage-II Breast Cancer: Tertiary Level Multicentered Study in Rajshahi, Bangladesh." SAS Journal of Surgery 7, no. 6 (June 4, 2021): 267–74. http://dx.doi.org/10.36347/sasjs.2021.v07i06.002.

Full text
Abstract:
Background: The purpose of this study was to Outcome Evaluation of Mastectomy with Axillary Dissection in Stage-II Breast Cancer. And satisfaction in patients who have undergone mastectomy. An Experimental study was conducted from December 2018 to Nov 2020 at Rajshahi Medical College Hospital. Total 556 patients, Breast conservation (partial mastectomy, axillary node dissection or sampling, and radiotherapy) is the current standard of care for eligible patients with Stages I and II breast cancer. Methods: A 2-year prospective analysis of the experience with breast reconstruction following Mastectomy with Axillary Dissection in Stage-II Breast Cancer was performed. Timing, quite mastectomy and reconstruction, complications, and cancer occurrence/recurrence were examined. Patients reported their level of satisfaction and willingness to undergo the procedure again. Outcomes of Mastectomy were graded by an independent and blinded group of surgeons. Results: Outcome of Mastectomy with Axillary Dissection in Stage-II Breast Cancer performed in 556patients following mastectomy. With a mean follow-up of 24 months, there were three breast-site complications in this group (3 percent). Patients in the study had a unilateral mastectomy; on the contralateral side with cancer, there were five breast-site complications in reconstructions following therapeutic mastectomy, patients 266 (48%) had the early-stage disease (0, I, II) at diagnosis. With 24 months median follow-up, complete control of axillary recurrence was achieved in 395 patients (71%). Distant metastases developed in 278 (50%) and were more likely with uncontrolled axillary recurrences. Failure to receive multimodality therapy and failure to undergo surgery for the recurrence correlated with resistant axillary disease. Conclusions: Mastectomy was as safe as or more. Safe than that following therapeutic mastectomy, which has been shown in other studies to end in a high percentage of patient satisfaction. Although .....
APA, Harvard, Vancouver, ISO, and other styles
41

Mahmood, U., A. L. Hanlon, M. Koshy, R. Buras, S. Chumsri, K. H. Tkaczuk, S. Cheston, W. Regine, and S. J. Feigenberg. "Early evidence of increasing national mastectomy rates for the treatment of breast cancer." Journal of Clinical Oncology 29, no. 27_suppl (September 20, 2011): 136. http://dx.doi.org/10.1200/jco.2011.29.27_suppl.136.

Full text
Abstract:
136 Background: The use of mastectomy for the treatment of breast cancer has declined since initial randomized trials demonstrated equivalent survival with breast conservation therapy. Recent single institution series, however, have reported increasing mastectomy rates within the past decade. Methods: In order to verify these findings at the national level, we analyzed data from the Surveillance, Epidemiology, and End Results database, including women diagnosed with T1-2 N0-3 M0 breast cancer from 2000 to 2007. We evaluated therapeutic mastectomy rates by the year of diagnosis and performed a multivariable logistic regression analysis to determine predictors of mastectomy as the treatment choice. Results: A total of 228,240 patients met the entry criteria. The proportion of women treated with mastectomy decreased from 40.3% to 35.6% between 2000 and 2005. Subsequently, the mastectomy rate increased to 37.9% in 2007 (p < 0.0001). The mastectomy rate in 2007 was the highest since 2002 (38.6%). A reversal in previously declining mastectomy rates was noted in nearly all cohorts, but was most pronounced among younger women. Multivariable analysis found that age, race, marital status, geographic location, involvement of multiple regions of the breast, lobular histology, increasing tumor size, lymph node positivity, increasing grade, negative hormone receptor status, and synchronous diagnosis of an ipsilateral or contralateral breast cancer were independent predictors of mastectomy. Additionally, multivariable analysis confirmed that women diagnosed in 2007 were more likely to undergo mastectomy than women diagnosed in 2005 (HR = 1.14, CI: 1.09 to 1.18, p < 0.0001). Conclusions: There is evidence of a reversal in the previously declining national mastectomy rates, with the mastectomy rate reaching a nadir in 2005 and subsequently rising. Further follow-up to confirm this trend and investigation to determine the underlying cause of this trend and its impact on outcomes are warranted.
APA, Harvard, Vancouver, ISO, and other styles
42

Babar, Arslan, Fahrettin Covut, Tariq Zuheir Kewan, Shafia Rahman, Stephen R. Grobmyer, and Alberto J. Montero. "Impact of mastectomy in women with stage IV HER2+ breast cancer." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): e12515-e12515. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e12515.

Full text
Abstract:
e12515 Background: Women with stage IV HER2+ breast cancer typically have longer overall survival (OS) compared to other breast cancer subsets due to the effectiveness of dual anti HER-2 antibody therapy. The role of mastectomy remains controversial. Methods: We reviewed patients who were diagnosed with stage IV HER2+ breast cancer between 2/2015 and 12/2017 at Cleveland Clinic. Overall survival (OS) was estimated by the Kaplan-Meier method, and compared by the log-rank test. Univariable and multivariable analysis were performed using Cox regression to identify predictors of OS. Results: We identified 47 patients, with a median age of 58 (range: 22 – 87). Twenty-eight (60%) and 14 (30%) patients had ER+ and PR+ disease, respectively. Four patients had brain metastasis at time of stage IV diagnosis. All patients received systemic therapy. 17 (36%) patients underwent mastectomy after diagnosis of stage IV breast cancer,. Of the 30 (64%) patients who did not undergo mastectomy, 24 (80%), 2 (7%), and 4 (13%) were treated with both chemotherapy and HER2-directed therapy, chemotherapy alone, and HER2-directed therapy alone, respectively. Breast radiotherapy was performed on 9 (53%) and 8 (27%) patients in mastectomy and no mastectomy cohorts, respectively. Median follow-up time was 22 months . The two-year OS for mastectomy and no mastectomy cohorts were 94% (95% CI: 83 – 100) and 50% (95% CI: 33 – 76), respectively (p=0.009). On univariable analysis, only mastectomy vs no mastectomy (HR: 0.18, 95% CI: 0.04 – 0.80, p=0.025) predicted OS. On multivariable analysis, mastectomy vs no mastectomy has remained to be statistically significant predictor of OS (HR: 0.08, 95% CI: 0.01 – 0.66, p=0.019), whereas age, chemotherapy, HER2-directed therapy, and breast radiation were not independent predictors of improved OS (p>0.05). Conclusions: In our cohort, mastectomy was an independent predictor of longer OS in women with stage IV HER2+ breast cancer.
APA, Harvard, Vancouver, ISO, and other styles
43

Hawley, S., R. Jagsi, A. S. Hamilton, J. Graff, J. J. Griggs, and S. J. Katz. "Factors associated with bilateral versus single mastectomy in a diverse, population-based sample of breast cancer patients." Journal of Clinical Oncology 27, no. 15_suppl (May 20, 2009): 6502. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.6502.

Full text
Abstract:
6502 Background: Rates of bilateral mastectomy are increasing in the U.S., even among women with cancer in only one breast. The goal of this analysis was to assess correlates of bilateral mastectomy in a large, racially/ethnically diverse sample of breast cancer patients. Methods: All women with ductal carcinoma-in-situ and a 20% random sample of women with invasive breast cancer aged < 79 years who were diagnosed in 2002 and reported to the Detroit and Los Angeles SEER registries were surveyed shortly after receipt of surgical treatment (response rate, 77.4%; n = 1,844). Patient survey data were merged with SEER data. The primary dependent variable, receipt of bilateral mastectomy, was obtained from patient report and validated by SEER. Independent variables included patient demographics, family history of breast cancer, tumor stage, and patient concerns about recurrence and body image. Logistic regression was used to evaluate factors associated with receipt of all mastectomy (including bilateral) vs. lumpectomy, and then to evaluate bilateral vs. single mastectomy. Results: The mean age was 60 years. 70% were white, 18% Black, and 12% Latina. Overall, 5% of women received bilateral mastectomy (13% of those getting mastectomy). The Table shows factors associated with receipt of any mastectomy vs. lumpectomy (model 1) and bilateral vs. single mastectomy (model 2). Advanced stage and concerns about recurrence were associated with increased odds of any mastectomy while body image concerns were associated with lumpectomy (P<0.05) (model 1). Model 2 shows family history (OR: 3.00; 95% CI 1.36–6.61) and concerns about recurrence (OR: 2.76, 95% CI 1.14–6.68) were associated with greater odds of receiving bilateral vs. single mastectomy. Conclusions: Decision making for any mastectomy vs. lumpectomy is quite different from that for bilateral vs. single mastectomy. The latter appears to be driven by genetic predisposition, but there continues to be a strong influence of women's concerns about recurrence. [Table: see text] No significant financial relationships to disclose.
APA, Harvard, Vancouver, ISO, and other styles
44

Yi, Min, Elizabeth Ann Mittendorf, Rosa F. Hwang, Gildy Babiera, Henry Mark Kuerer, Jaime Crow, Georgia Lange, Ruchita R. Shah, and Kelly Hunt. "Are mastectomy rates really increasing? Experiences from a single institution and a population-based database." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): 1028. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.1028.

Full text
Abstract:
1028 Background: Recent studies have reported increased mastectomy rates for the treatment of early stage breast cancer during the last decade. The aims of this study were to examine trends in mastectomy rates at a single institution and in a population-based database and to compare differences between the two cohorts. Methods: Patients with stage 0-II breast cancer diagnosed from 2000 to 2008 were identified from our cancer center institutional database (CC cohort, n=8,915) and the Surveillance, Epidemiology and End Results database (SEER cohort, n=359,572). Patients without primary surgery or unknown surgery type were excluded. Mastectomy rates by the year of diagnosis were evaluated and multivariable logistic regression models were built to identify clinicopathologic factors that predicted mastectomy as the treatment choice. Results: The proportion of patients treated with mastectomy decreased from 44.5% to 37.8% between 2000 and 2005 in the CC cohort (P=0.003) and from 42.8% to 36.6% in the SEER cohort (P<0.0001). Subsequently, the mastectomy rate increased to 48.6% in the CC cohort (P<0.0001) and to 40.1% in the SEER cohort by 2008 (P<0.0001). Multivariable analysis found that patients with younger age (<50), stage 0 or II cancer vs. stage I, high grade tumor, low median household income, and lobular histology were more likely to choose mastectomy in both the SEER and CC cohorts. In the CC cohort, patients with preoperative breast MRI were also more likely to undergo mastectomy. The percentages of patients receiving preoperative MRI and choosing prophylactic contralateral mastectomy increased each year in the CC cohort. The rate of preoperative breast MRI increased from 4.7% in 2005 to 9.6% in 2008 (P<0.0001). Patients choosing prophylactic contralateral mastectomy increased from 8.4% in 2005 to 11.8% in 2008 (P=0.06). Conclusions: Our study shows that there was a decrease in mastectomy rates from 2000 to 2005 and a subsequent increase in mastectomy rates from 2005-2008 in both the CC and SEER cohorts. Increased use of preoperative breast MRI and the decision to undergo contralateral prophylactic mastectomy likely contributed to the increased mastectomy rates in the CC cohort.
APA, Harvard, Vancouver, ISO, and other styles
45

Pierotti, Matthew Lewis, Christian X. Cruz Pico, Jill S. Hasler, Austin David Williams, Elizabeth A. Handorf, Allison A. Aggon, Mary Pronovost, Andrea S. Porpiglia, Mahtab Vasigh, and Richard J. Bleicher. "10-year mastectomy trends among breast cancer phenotypes: A national cohort study." Journal of Clinical Oncology 41, no. 16_suppl (June 1, 2023): 584. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.584.

Full text
Abstract:
584 Background: Breast cancer tumor phenotype has prognostic value with triple negative (TN) cancers having higher rates of distant metastases early. While tumor phenotypes are prognostic, published data demonstrates that the choice of local therapy does not affect this predisposition or affect survival. This study was performed to determine whether mastectomy is being performed more frequently for TN or HER2+ phenotypes, relative to hormone receptor positive (HR+) phenotypes despite the lack of benefit this should provide. Methods: Data from the National Cancer Database (NCDB) was analyzed from 2010 through 2019 to assess mastectomy trends and associations with patient and tumor characteristics. Women with invasive breast cancer were included. Women with Stage IV disease were excluded. Patients were categorized as mastectomy or breast conservation surgery. Patient and tumor characteristics were compared across groups using chi-square and Wilcoxon rank sum tests, and a multivariable logistic regression model was fit to assess the association between mastectomy and tumor phenotype controlling for patient and tumor characteristics. Results: 543,590 patients were evaluated. 173,380 (31.9%) patients underwent mastectomy, and 370,210 (68.1%) patients underwent breast conservation surgery. Mean age at diagnosis was 56. There were 425,174 HR+, 64,960 HER2+, and 53,456 TN tumors. The proportion of patients undergoing mastectomy peaked in 2013 at 36.14% before declining. Compared to HR+, HER2+ patients were more likely to undergo mastectomy, OR 1.39 p < 0.0001 (95% CI 1.35 – 1.43); however, there was no significant difference in mastectomy between HR+ patients and TN patients. Compared to whites, black patients were less likely to undergo mastectomy, OR 0.71 p < 0.0001 (95% CI 0.69 – 0.74), and individuals of Hispanic ethnicity less likely to undergo mastectomy, OR 0.92 p < 0.0001 (95% CI 0.89 – 0.95). Compared to private insurance, Medicare had a greater association with mastectomy, OR 1.2 p < 0.0001 (95% CI 1.18 – 1.23). There was no significant difference between other forms of insurance (Medicaid, other government insurance, no insurance) and private insurance. Education and income were not associated with different frequencies of mastectomy. Patients with higher comorbidity scores were more likely to undergo mastectomy. Conclusions: Mastectomy rates have been declining since 2013 at CoC centers. While TN breast cancer is not associated with increased mastectomy percent, mastectomy continues to be performed more frequently for HER2+ positive phenotype when adjusting for tumor and patient characteristics. These data suggest a need for education about HER2 positive phenotype due to a possible lack of understanding about the why such tumors pose a risk, and the role of local therapy in treating them.
APA, Harvard, Vancouver, ISO, and other styles
46

Pestana, Ivo, and Nicholas Walker. "Autologous Breast Reconstruction Skin Paddle Designs: Classification and Aesthetic Outcomes." Journal of Reconstructive Microsurgery Open 04, no. 01 (January 2019): e29-e35. http://dx.doi.org/10.1055/s-0039-1688725.

Full text
Abstract:
Objective Present study was conducted to identify common mastectomy patterns and autologous skin paddle designs, to identify patient characteristics that influence these patterns, and assess aesthetic outcomes associated with each pattern. Methods Autologous breast reconstructions over 5 years were reviewed. Mastectomy type and resultant skin paddle were categorized into four mastectomy type/skin paddle design groups based on the amount of native “Skin Spared” after mastectomy and the resultant flap skin paddle designed. Groups were designated as skin-sparing mastectomy 1 (SS1)/large elliptical skin paddle, skin-sparing mastectomy 2 (SS2)/small elliptical skin paddle, skin-sparing mastectomy 3 (SS3)/areola skin paddle, and skin-sparing mastectomy 4 (nipple-sparing mastectomy, SS4)/no skin paddle. Surveys were performed to validate the classification system and critique aesthetic outcomes. Results A total of 89 autologous breast reconstructions were included. Radiotherapy was used in 45.6% of SS1 patients versus 29.2% in SS2 and 12.5% in SS3/SS4. Mean body mass index (BMI) was 30 in SS1/SS2 and 26 in SS3/SS4 mastectomy types (p = 0.045). Delayed reconstruction was performed in 96.5% SS1 versus 62.5% in SS2 and only 25% of SS3/SS4 (p < 0.0001). Physicians and Non-MD personnel correctly categorized 85.8 and 76.1% of skin paddle designs, respectively. Over 75% of those surveyed rated the reconstruction aesthetic outcome as “good-excellent” regardless of the pattern group. Conclusions Patients in SS1/SS2 groups had a higher incidence of radiotherapy, delayed reconstruction, and higher BMI compared with the SS3/SS4 groups. The classification system is recognizable and may provide improved patient education and communication between healthcare providers. All mastectomy type/skin paddle designs received high aesthetic ratings.
APA, Harvard, Vancouver, ISO, and other styles
47

Lucas, Donald J., Jennifer Sabino, Craig D. Shriver, Timothy M. Pawlik, Devinder P. Singh, and Amy E. Vertrees. "Doing More: Trends in Breast Cancer Surgery, 2005 to 2011." American Surgeon 81, no. 1 (January 2015): 74–80. http://dx.doi.org/10.1177/000313481508100133.

Full text
Abstract:
An increasing number of women may be choosing mastectomy over breast-conserving surgery for breast cancer as well as undergoing more bilateral resection, immediate reconstruction, and prophylactic operations. Women who had breast cancer operations between 2005 and 2011 were selected from the National Surgical Quality Improvement Program database. Annual trends were explored using robust Poisson multivariable regression as were predictors for mastectomy versus breast-conserving surgery. A total of 85,401 women were identified. Mastectomy increased from 2005 to 2011, starting at 40 per cent in 2005 and peaking at 51 per cent in 2008 ( P < 0.001). Bilateral resection, immediate reconstruction, and prophylactic mastectomy also increased (all P < 0.001). Independent predictors of mastectomy included young age, Asian race, invasive cancer (vs carcinoma in situ), bilateral resection, axillary dissection, higher American Society of Anesthesiologists class, and lower body mass index (all P < 0.001). There was an increase in mastectomy, bilateral resection, immediate reconstruction, and prophylactic mastectomy from 2005 to 2011.
APA, Harvard, Vancouver, ISO, and other styles
48

Shin, Kristina, Kaoru Leung, Fred Han, and Jiao Jiao. "Thermal and moisture control performance of different mastectomy bras and external breast prostheses." Textile Research Journal 90, no. 7-8 (October 22, 2019): 824–37. http://dx.doi.org/10.1177/0040517519881815.

Full text
Abstract:
This paper introduces a project involving a thermoregulation performance experiment design to evaluate the different responses of research subjects to a range of mastectomy bras and external breast prostheses. A set of newly designed heat-reduction mastectomy bras and prostheses were mix-matched with a set of conventional mastectomy bras and prostheses for the experiment. Four combinations of mastectomy bras and external breast prostheses were used: (a) Com A: conventional mastectomy bra and conventional prosthesis; (b) Com B: conventional mastectomy bra and heat-reduction prosthesis; (c) Com C: heat-reduction mastectomy bra and conventional prosthesis; and (d) Com D: heat-reduction mastectomy bra and heat-reduction prosthesis. Nine healthy male subjects (mean age: 31.9 ± 5.9 y and mean under-bust circumference: 35.3 ± 2.8 in) participated in this study in lieu of women who had undergone surgery for double mastectomy and were too self-conscious to expose their scars for sensor attachment. Eight sets of temperature and humidity sensors were placed between the surface of the skin and the prostheses and bra to measure the changes in both temperature and humidity data in a microclimate environment while the participants performed physical activity. The results showed that Com D demonstrated better thermal and moisture control, resulting in lower body temperature and lower humidity increment throughout the entire experiment. The study proved that the heat-reduction mastectomy bra and external breast prosthesis were effective in releasing the trapped heat and perspiration underneath the bra, and thus would provide a positive impact on clothing comfort and wearing experience for women who had undergone mastectomies.
APA, Harvard, Vancouver, ISO, and other styles
49

Harding, C., F. Pompei, D. Burmistrov, and R. Wilson. "Use of Mastectomy for Overdiagnosed Breast Cancer in the United States: Analysis of the SEER 9 Cancer Registries." Journal of Cancer Epidemiology 2019 (January 22, 2019): 1–14. http://dx.doi.org/10.1155/2019/5072506.

Full text
Abstract:
Aim. We investigated use of mastectomy as treatment for early breast cancer in the US and applied the resulting information to estimate the minimum and maximum rates at which mastectomy could plausibly be undergone by patients with overdiagnosed breast cancer. Little is currently known about overtreatments undergone by overdiagnosed patients. Methods. In the US, screening is often recommended at ages ≥40. The study population was women age ≥40 diagnosed with breast cancer in the US SEER 9 cancer registries during 2013 (n=26,017). We evaluated first-course surgical treatments and their associations with case characteristics. Additionally, a model was developed to estimate probability of mastectomy conditional on observed case characteristics. The model was then applied to evaluate possible rates of mastectomy in overdiagnosed patients. To obtain minimum and maximum plausible rates of this overtreatment, we respectively assumed the cases that were least and most likely to be treated by mastectomy had been overdiagnosed. Results. Of women diagnosed with breast cancer at age ≥40 in 2013, 33.8% received mastectomy. Mastectomy was common for most investigated breast cancer types, including for the early breast cancers among which overdiagnosis is thought to be most widespread: mastectomy was undergone in 26.4% of in situ and 28.0% of AJCC stage-I cases. These rates are substantively higher than in many European nations. The probability-based model indicated that between >0% and <18% of the study population could plausibly have undergone mastectomy for overdiagnosed cancer. This range reduced depending on the overdiagnosis rate, shrinking to >0% and <7% if 10% of breast cancers were overdiagnosed and >3% and <15% if 30% were overdiagnosed. Conclusions. Screening-associated overtreatment by mastectomy is considerably less common than overdiagnosis itself but should not be assumed to be negligible. Screening can prompt or prevent mastectomy, and the balance of this harm-benefit tradeoff is currently unclear.
APA, Harvard, Vancouver, ISO, and other styles
50

Lim, David Wai, Helene Retrouvey, Isabel Kerrebijn, Kate Butler, Anne C. O'Neill, Tulin Cil, Toni Zhong, Stefan Hofer, David R. McCready, and Kelly A. Metcalfe. "Psychosocial outcomes following surgery in women with unilateral, nonhereditary breast cancer." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): 570. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.570.

Full text
Abstract:
570 Background: Rates of bilateral mastectomy continue to rise in average-risk women with unilateral breast cancer. We aim to characterize psychosocial predictors of surgical procedure and how psychosocial outcomes change over time after surgery for breast cancer. Methods: A prospective cohort of women with unilateral, nonhereditary breast cancer were recruited at University Health Network in Toronto, Canada between 2014-2017. Women completed validated psychosocial questionnaires (BREAST-Q) pre-operatively, and 6 and 12 months after surgery. Outcomes were assessed between three surgical groups (unilateral lumpectomy, unilateral mastectomy, bilateral mastectomy). Predictors of surgical procedure were identified using a multinomial logistic regression model. Change in psychosocial scores over time according to procedure was assessed using linear mixed models. All models control for age, stage, reconstruction and treatment. P values < .05 were considered statistically significant. Results: 506 women underwent surgery as follows: 216 unilateral lumpectomy (43%), 181 unilateral mastectomy (36%) and 109 bilateral mastectomy (22%). In the multinomial regression model, younger age (p < .01), and lower chest physical (p = .03) and sexual well-being (p = .02) predicted having bilateral mastectomy over unilateral lumpectomy while younger age (p < .01) and lower disease stage (p = .02) predicted bilateral mastectomy over unilateral mastectomy. The mixed model demonstrates that breast satisfaction follows a non-linear pattern of change over time, with 6- but not 12-month scores being significantly different from baseline (p = .015). Procedure predicts baseline satisfaction (p = .016), with bilateral mastectomy having worse satisfaction than unilateral lumpectomy. Procedure also predicts change in satisfaction, with unilateral and bilateral mastectomy having lower scores across time than lumpectomy. While a significant improvement in psychological well-being is detected by 12 months (p = .02), those with unilateral and bilateral mastectomy have worse psychological well-being over time compared to lumpectomy. Women having mastectomy start with worse physical well-being than those in the lumpectomy group, but their physical well-being does not decline as much as the lumpectomy group over time (p < .01). Conclusions: Definitive surgical procedure affects the trajectory of psychosocial functioning over time. This emerging data may be used to further facilitate surgical decision-making in women considering contralateral prophylactic mastectomy.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'Mastectomy' for other source types:
Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography